v3.26.1
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Jun. 30, 2026
Dec. 31, 2025
Current Assets:    
Cash and cash equivalents $ 693,453 $ 575,817
Accounts receivable (less allowance for credit losses of $265 at June 30, 2026 and $833 at December 31, 2025) 296,893 253,207
Investments - current 8,258 28,413
Prepaid expenses and other current assets 161,845 94,140
Total current assets 1,160,449 951,577
Property and equipment, net 66,211 64,251
Right of use asset, net 7,304 7,019
Goodwill 32,060 32,060
Intangible assets, net 4,550 4,550
Other assets 8,464 6,329
Total assets 1,279,038 1,065,786
Current Liabilities:    
Medical expenses payable 612,748 474,569
Accounts payable and accrued expenses 32,270 33,284
Accrued compensation 38,389 49,013
Total current liabilities 683,407 556,866
Long-term debt, net of debt issuance costs 324,056 323,176
Long-term portion of lease liabilities 6,444 6,467
Total liabilities 1,013,907 886,509
Commitments and Contingencies (Note 12)
Stockholders' Equity:    
Preferred stock, $0.001 par value; 100,000,000 shares authorized as of June 30, 2026 and December 31, 2025, respectively; no shares issued and outstanding as of June 30, 2026 and December 31, 2025 0 0
Common stock, $0.001 par value; 1,000,000,000 shares authorized as of June 30, 2026 and December 31, 2025; 207,178,193 and 204,153,619 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively 207 205
Additional paid-in capital 1,225,965 1,188,089
Accumulated deficit (961,041) (1,009,017)
Total stockholders' equity 265,131 179,277
Total liabilities and stockholders' equity $ 1,279,038 $ 1,065,786